Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib versus dutasteride for frontal fibrosing alopecia
RBR-3jm8kscNot yet recruiting
- Sponsor
- Hospital Universitário Pedro Ernesto
- Start
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, triple-blind trial in frontal fibrosing alopecia (FFA) comparing Tofacitinib with Dutasteride (2 arms). Planned start Nov 2026; status: not yet recruiting.
02
Drugs
tofacitinibdutasteride
03
Conditions
frontal fibrosing alopecia (FFA)
Beyond the preview
Go deeper on RBR-3jm8ksc.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-3jm8ksc.